Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer. | Cell Biosci | 2023 | 37580808 | PubTator, text mining | PubMed |
| Leveraging osteoclast genetic regulatory data to identify genes with a role in osteoarthritis. | Genetics | 2023 | 37579195 | PubTator, text mining | PubMed |
| Diagnostic value of aberrant decreased 5-Methylcytosine RNA modification in leukocytes for non-small cell lung cancer. | J Cancer | 2023 | 37576401 | PubTator, text mining | PubMed |
| Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m6A modification promotes DNA damage in human bronchial epithelial cells. | Environ Pollut | 2023 | 37573961 | PubTator, text mining | PubMed |
| Co-effects of m6A and chromatin accessibility dynamics in the regulation of cardiomyocyte differentiation. | Epigenetics Chromatin | 2023 | 37568210 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma. | BMC Genom Data | 2023 | 37568073 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression. | Cell Commun Signal | 2023 | 37563688 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications. | Heliyon | 2023 | 37560684 | PubTator, text mining | PubMed |
| Analysis of the role of glucose metabolism-related genes in dilated cardiomyopathy based on bioinformatics. | J Thorac Dis | 2023 | 37559624 | PubTator, text mining | PubMed |
| Targeted mRNA demethylation in Arabidopsis using plant m6A editor. | Plant Methods | 2023 | 37559087 | PubTator, text mining | PubMed |
| PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6. | Cell Death Dis | 2023 | 37558663 | PubTator, text mining | PubMed |
| Role of TNF-α-induced m6A RNA methylation in diseases: a comprehensive review. | Front Cell Dev Biol | 2023 | 37554306 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors. | Theranostics | 2023 | 37554271 | PubTator, text mining | PubMed |
| Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy. | Genes Dis | 2023 | 37554217 | PubTator, text mining | PubMed |
| m6A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer. | Genes Dis | 2023 | 37554195 | PubTator, text mining | PubMed |
| The crucial roles of m6A RNA modifications in cutaneous cancers: Implications in pathogenesis, metastasis, drug resistance, and targeted therapies. | Genes Dis | 2023 | 37554186 | PubTator, text mining | PubMed |
| Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells. | Discov Oncol | 2023 | 37552314 | PubTator, text mining | PubMed |
| Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease. | PLoS One | 2023 | 37549144 | PubTator, text mining | PubMed |
| Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma. | Oncol Res | 2023 | 37547754 | PubTator, text mining | PubMed |
| Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract. | World J Diabetes | 2023 | 37547588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=45